Protein arginine methylation promotes global 3′UTR shortening in proliferating cells
Molecular Cell · 2026
DOI: 10.1016/j.molcel.2026.10.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026. Verfasst von Llywelyn Griffith und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Francis Crick Institute, London, UK; UK Dementia Research Institute at King's College London, London, UK; Department of Basic and Clinical Neuros…. Hauptthemen laut MEDLINE: 3' Untranslated Regions, Protein-Arginine N-Methyltransferases, Arginine, Cell Proliferation. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, UK Dementia Research Institute, Wellcome Trust.
Abstract (Originalsprache)
Protein arginine methyltransferases (PRMTs) are promising anti-cancer targets, but their tumorigenic mechanisms remain incompletely understood. Here, we show that arginine methylation drives global 3'UTR shortening, thereby promoting oncogenic short isoforms. Inhibition of asymmetric dimethylation reverses this shift, with combined inhibition of asymmetric and symmetric dimethylation (DMAi) producing an even greater effect across human cancer cell lines, patient-derived organoids, and activated murine T cells, while also counteracting the shortening induced by reduced CFIm25 expression. Arginine methylation promotes PCF11 association with the cleavage and polyadenylation machinery, enabling efficient processing of weak proximal poly(A) sites within transcripts characterized by high GC content, large distances between alternative poly(A) sites, and a position-dependent sequence code. These findings establish physiologic roles of PRMTs in promoting 3'UTR shortening, which could be exploited for patient stratification of PRMT-targeting therapies in oncology and immune-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Francis Crick Institute, London, UK; UK Dementia Research Institute at King's College London, London, UK; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's Col…
- Oncology Targeted Discovery, Oncology R&D, AstraZeneca, Cambridge, UK.
- Hull York Medical School and York Biomedical Research Institute, University of York, York, UK.
- UK Dementia Research Institute at King's College London, London, UK; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
- The Francis Crick Institute, London, UK.
Förderung
- European Research Council
- UK Dementia Research Institute
- Wellcome Trust
- Medical Research Council
- The Francis Crick Institute
- Cancer Research UK
Zitieren
APA
Griffith, L., Capitanchik, C., Moore, S., Farcas, A., Gwynne, M., Pedna, M., Vukšinić, I., Bračič, V., Davey, K., Jones, D. M., Chakrabarti, A. M., Lagos, D., Urosevic, J., Lynch, J. T., & Ule, J. (2026). Protein arginine methylation promotes global 3′UTR shortening in proliferating cells. Molecular Cell. https://doi.org/10.1016/j.molcel.2026.10.003
Vancouver
Griffith L, Capitanchik C, Moore S, Farcas A, Gwynne M, Pedna M, et al. Protein arginine methylation promotes global 3′UTR shortening in proliferating cells. Molecular Cell. 2026. doi:10.1016/j.molcel.2026.10.003
BibTeX
@article{Griffith2026,
author = {Griffith, Llywelyn and Capitanchik, Charlotte and Moore, Shaun and Farcas, Anca and Gwynne, Mags and Pedna, Martina and Vukšinić, Ivana and Bračič, Veronika and Davey, Karen and Jones, D Marc and Chakrabarti, Anob M and Lagos, Dimitris and Urosevic, Jelena and Lynch, James T and Ule, Jernej},
title = {Protein arginine methylation promotes global 3′UTR shortening in proliferating cells},
journal = {Molecular Cell},
year = {2026},
doi = {10.1016/j.molcel.2026.10.003}
}
EUVIMED